|
|
|
Insider
Information: |
White William Richard |
Relationship: |
|
City: |
South San Francisco |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
49,630 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
49,630 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Akero Therapeutics, Inc. |
AKRO |
|
2024-03-13 |
49,630 |
2019-12-31 |
0 |
Premium* |
|
Ventyx Biosciences, Inc. |
VTYX |
Director |
2023-01-23 |
0 |
2023-01-23 |
0 |
Premium* |
|
Disc Medicine, Inc |
IRON |
|
2024-05-01 |
0 |
2023-12-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
46 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-12-21 |
4 |
OE |
$7.01 |
$701 |
D/D |
100 |
3,377 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-12-21 |
4 |
AS |
$22.00 |
$2,200 |
D/D |
(100) |
3,277 |
0 |
- |
|
IRON |
Disc Medicine, Inc |
|
|
2024-05-01 |
4 |
AS |
$28.52 |
$5,755 |
D/D |
(201) |
0 |
0 |
% |
|
IRON |
Disc Medicine, Inc |
|
|
2024-05-01 |
4 |
OE |
$9.86 |
$1,982 |
D/D |
201 |
201 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2023-06-13 |
4 |
AS |
$55.16 |
$33,427 |
D/D |
(606) |
22,377 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2023-12-14 |
4 |
S |
$20.76 |
$12,684 |
D/D |
(611) |
50,354 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2023-09-13 |
4 |
AS |
$50.34 |
$31,815 |
D/D |
(632) |
18,468 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2023-03-10 |
4 |
D |
$43.47 |
$27,864 |
D/D |
(641) |
22,983 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2024-03-13 |
4 |
S |
$28.33 |
$20,511 |
D/D |
(724) |
49,630 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2022-12-28 |
4 |
OE |
$7.01 |
$7,002 |
D/D |
999 |
24,623 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2022-12-28 |
4 |
AS |
$49.76 |
$49,714 |
D/D |
(999) |
23,624 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2019-12-31 |
4 |
A |
$18.87 |
$19,338 |
D/D |
1,025 |
1,025 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2022-06-30 |
4 |
A |
$8.03 |
$9,251 |
D/D |
1,152 |
4,429 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2020-06-30 |
4 |
A |
$17.07 |
$21,250 |
D/D |
1,245 |
2,270 |
0 |
- |
|
IRON |
Disc Medicine, Inc |
|
|
2024-04-11 |
4 |
OE |
$2.65 |
$12,581 |
D/D |
2,560 |
2,560 |
0 |
- |
|
IRON |
Disc Medicine, Inc |
|
|
2024-04-11 |
4 |
AS |
$31.79 |
$81,407 |
D/D |
(2,560) |
0 |
0 |
% |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-12-17 |
4 |
OE |
$7.01 |
$22,429 |
D/D |
3,200 |
6,477 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-12-17 |
4 |
AS |
$22.04 |
$70,528 |
D/D |
(3,200) |
3,277 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-05-03 |
4 |
AS |
$30.56 |
$128,352 |
D/D |
(4,200) |
2,270 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-05-03 |
4 |
OE |
$7.01 |
$29,438 |
D/D |
4,200 |
6,470 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-08-02 |
4 |
OE |
$7.01 |
$31,127 |
D/D |
4,441 |
7,718 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-08-02 |
4 |
AS |
$22.03 |
$97,835 |
D/D |
(4,441) |
3,277 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-07-06 |
4 |
AS |
$24.52 |
$159,380 |
D/D |
(6,500) |
3,277 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-07-06 |
4 |
OE |
$7.01 |
$45,559 |
D/D |
6,500 |
9,777 |
0 |
- |
|
AKRO |
Akero Therapeutics, Inc. |
Chief Financial Officer |
|
2021-10-01 |
4 |
AS |
$22.06 |
$143,367 |
D/D |
(6,500) |
3,277 |
0 |
- |
|
46 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|